Evidence map›Paper›PMID 37206192›Full record

ArticleJournal of Taibah University Medical Sciences2023

Quality of life of a sample of people with keratoconus in KSA.

Saleha K Alatawi

Abstract read
In one paragraph

Article in Journal of Taibah University Medical Sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Saleha K AlatawiFaculty of Applied Medical Science, Al Baha University, KSA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study sought to translate the Keratoconus Outcomes Research Questionnaire (KORQ) and using it to measure and evaluate the quality of life of a sample of people with keratoconus in KSA. Methods: A cross-sectional online survey of patients with keratoconus, drawn by convenience sampling from across several regions of KSA, was conducted. The data were analysed with appropriate quantitative techniques. Results: Ninety-one patients with keratoconus (57.1% men; mean age = 33.25 ± 6.72 years) from five regions of KSA completed the survey. A total of 78.1% of the cases were diagnosed when the respondents were 15-29 years of age. Of the 91 participants, 11%, 27%, and 30% reported no, mild, and moderate interference with activities, whereas 17% and 15% reported substantial activity limitations. Regarding symptoms, 8%, 20%, and 24% reported no, mild, and moderate symptoms, whereas 23% and 25% reported substantial and extreme symptoms, respectively. Pearson rank correlation analysis indicated strong and statistically significant coefficients among the coded scores for symptoms, activity limitations and demographic factors. Regression analysis of the relationship between the scores for symptoms/activity limitations and demographic factors indicated that only the scores for visual acuity, eye with keratoconus, and geographic region were statistically significant at 5%. Visual acuity while wearing glasses or lenses and the odds of having poor QoL score were higher in both the left and right eyes [23.85 (95% CI, 4.21 to 135.24) and 6.0 (95% CI, 1.12 to 32.12), respectively]. Unknown visual acuity is associated with greater odds of higher annoyance scores [4.69 (95% CI, 1.06 to 20.62) and 13.63 (95% CI, 2.74 to 67.74), respectively]. Conclusion: Patients experience substantial impairments in their daily lives that could potentially be mitigated by addressing visual acuity, specific (left, right or both) eyes with keratoconus, and regional variables.

Indexed as

Corrected visual acuityCross-sectional studyKeratoconus outcomes research questionnaire (KORQ)Keratoconus stageQuality of lifeVisual acuity

Identifiers

PMID37206192
PMCPMC10189266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.